Michelle Arkin is a Professor of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF). She is also a director of the Small Molecule Discovery Center (SMDC), a chemical biology and drug discovery center at UCSF. Michelle has extensive experience in the field of drug discovery and is working on new and complex challenges to demonstrate 'druggability' of new target classes. Michelle is also the cofounder of Ambagon Therapeutics who are building on the concepts of modulating protein-protein interactions to find new drugs that address unmet needs in cancer, metabolic disorders, neurodegeneration and infectious diseases.- Small Molecule Discovery Center: https://pharm.ucsf.edu/smdc- Arkin Lab: https://pharm.ucsf.edu/arkin

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related